Xbox didn't enter 2025 in a great state, and it's leaving the year grasping for help, like an Arc Raider player desperate for ...

PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040 THIS DECISION STRENGTHENS MASITINIB’S ...

Five studies presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition reveal new opportunities to improve care for people living with sickle cell disease.

Longtime English studio Splash Damage is facing an uncertain future as it begins a consultation process that will affect all staff and likely lead to layoffs. On November 26, Splash Damage publicly ...

JAMES CITY COUNTY, Va. (WAVY) – CEL Critical Power has invested $5.225 million to open its first facility in James City County to produce power for data centers. The Dublin-based manufacturer plans to ...

JAMES CITY COUNTY, Va. — CEL Critical Power, a global provider of power solutions, will invest $5.2 million to open its first American manufacturing facility in James City County, Governor Glenn ...

Please provide your email address to receive an email when new articles are posted on . Patients with sickle cell disease and beta-thalassemia reported substantial improvements in quality of life ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 3 minutes ...

A multi-institutional study led by researchers at the University of Alabama at Birmingham and the University of North Carolina at Chapel Hill has revealed a previously underappreciated mechanism by ...

Hi-Fi Rush drew in more than three million players, but that wasn't enough to save Tango Gameworks. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

NASA proposes to pioneer a radically new approach to mitigating radiation-induced cell damage in astronauts by transplanting new undamaged mitochondria (critical radiation-sensitive cell organelles) ...

Obecabtagene autoleucel showed effective outcomes in both younger and older adults with relapsed/refractory B-cell acute lymphoblastic leukemia, with similar remission rates and chimeric antigen ...